Toronto, Ontario (PRWEB) September 12, 2011 -- Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading companies, today announced that the Company is scheduled to attend ChemOutsourcing, an annual pharmaceutical chemistry conference taking place in Long Branch, New Jersey from September 12 – 15, 2011.
The conference is a convergence for biotech and pharma companies, professionals and executives focusing on chemistry outsourcing, process R&D, medicinal chemistry, drug discovery and procurement. Peter Pekos, President and CEO of Dalton Pharma Services will be representing the Company at ChemOutsourcing and looks forward to discussing your drug development and manufacturing needs with you.
About Dalton:
Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufacturer that supplies chemistry, analytical and formulation development services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry and fine chemical manufacture. Dalton provides cGMP manufacturing of solid dosage forms and aseptic filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities, Dalton produces active pharmaceutical ingredients at the gram or kilogram scale. Dalton conducts sterile fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilized, under fully validated conditions. In addition, Dalton’s analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients. Further information can be found at http://www.dalton.com.
Contact:
Peter Pekos
President & CEO
Dalton Pharma Services Inc.
349 Wildcat Road
Toronto, Ontario
Tel: 416-661-2102
